Savvy Updates, 5/3/21: Farxiga for Chronic Kidney Disease, Sernova and the Cure for T1D, Beta Cells Stress Response, T1D 50-year Medalists
FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease was reported by Susan Jeffrey for Medscape.com, 30 April 2021. The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for...
Savvy Updates, 4/26/21: DIY Loop Study, iGlobe Advanced CGM, BioPrinted Pancreas, Medtronic 7-day Infusion Set, Diabetes Waste Disposal
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System was published on Liebertpub.com, 12 April 2021. This is a very exciting and important study, validating the effectiveness and safety of those...
Savvy Updates, 4/19/21: T1D pill gets FDA breakthrough designation, Home HbA1c kits, Bioactive Glass Toothpaste
FDA grants breakthrough therapy designation for novel type 1 diabetes pill was reported by Regina Schaffer for Healio.com/endocrinology, 14 April 2021. The FDA granted breakthrough therapy designation for TTP399 as an adjunctive therapy to insulin for the...
Savvy T1D Research and AI, 4/14/21: Digital Diabetes Analytics, Insulin 100 (A Scientific Symposium)
The Loop and Learn T1D Speakers series hosted the 3 founders of Digital Diabetes Analytics, all the way from Sweden. It was a very interesting presentation, about their work to develop algorithms for machine learning, based on CGM data, for their current...
Savvy Updates, 4/12/21: Oral Insulin Release Pill, Connected In Motion, Beta Cell Foundation, Vertex CEO Earns $9.1m
Experimental oral pills auto-release insulin when glucose levels are high was reported by Michael Irving for NewAtlas.com/medical, 7 April 2021. Researchers at NYU Abu Dhabi have developed a system that can do just that. The team created what they call...
More Diabetes Blogs